Pharmaceutical company Sanofi is recalling all of its injectors used to treat severe allergic reactions.
The French drug and vaccine maker, whose injectors compete with Mylan’s EpiPen, is recalling all Auvi-Q injections currently on the U.S. market, which is about 490,000 packs, ABC reports, over concerns that they may not administer the correct amount of the drug.
Sanofi said it has received 26 reports of problems with the injectors, none of which resulted in the patient’s death. About 200,000 people in the United States use Sanofi’s product.
- Exclusive: The Making of the U.S. Military's New Stealth Bomber
- Your Next House Could Be Made on an Assembly Line
- The Legal Implications of the Debate Over Whether 'Extreme Racism' Is a Mental Illness
- Why European Countries Are Giving Teens Free Money To Spend on Books, Music, and Theater
- Republican Skepticism of Trump Has Never Been Higher
- Column: The U.S. Prison System Doesn't Value True Justice
- How Green Is the Qatar World Cup’s Outdoor AC?
- 16 Funny and Whimsical White Elephant Gifts Under $25
- The 5 Best New TV Shows Our Critic Watched in November 2022